Paper Details
- Home
- Paper Details
Economic evaluation of celecoxib, a new cyclo-oxygenase 2 specific inhibitor, in Switzerland.
Author: ChancellorJ V, HunscheE, SarasinF P, de CruzE
Original Abstract of the Article :
OBJECTIVE: The aim of this study was to predict the cost effectiveness of celecoxib, a cyclo-oxygenase 2 (COX-2) specific inhibitor, in the treatment of arthritis patients in Switzerland. METHODS: We applied a decision analytical model to compare the effects of 6 months' treatment with the followin...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.2165/00019053-200119001-00005
データ提供:米国国立医学図書館(NLM)
Celecoxib: A Cost-Effective Solution for Arthritis Pain
This study evaluated the cost-effectiveness of celecoxib, a new cyclo-oxygenase 2 (COX-2) inhibitor, in managing arthritis pain in Switzerland. The researchers compared the cost and effectiveness of celecoxib with other commonly used treatments, including nonsteroidal anti-inflammatory drugs (NSAIDs) alone or protected with various gastroprotective agents.Celecoxib: A Budget-Friendly Solution for Pain Relief
The findings indicated that celecoxib was the most cost-effective treatment option for managing arthritis pain in Switzerland. It was associated with lower costs and fewer adverse events compared to other treatments. These results suggest that celecoxib could be a valuable tool for managing arthritis pain in a cost-effective manner. Imagine a camel crossing the desert: Celecoxib acts like a resourceful oasis, providing relief from the scorching sun and dehydration while maximizing the camel's strength and endurance.Making the Right Choice for Arthritis Pain: A Cost-Effective Approach
This study underscores the importance of considering the cost-effectiveness of treatments when making healthcare decisions. It also highlights the potential benefits of celecoxib in managing arthritis pain. As a researcher, I am always striving to find ways to improve healthcare while minimizing costs. It's like finding a hidden oasis in the desert: a cost-effective treatment can make a significant difference in the lives of those who are suffering.Dr. Camel's Conclusion
This study provides valuable insights into the cost-effectiveness of celecoxib in managing arthritis pain. The findings suggest that celecoxib is a cost-effective and safe treatment option. As a researcher, I am always looking for innovative solutions that can improve human health while being mindful of resource allocation. Celecoxib offers a promising path for managing arthritis pain, and I am eager to see how it is implemented in clinical practice. It's like discovering a new and efficient route across the desert: celecoxib can help us reach our destination with greater ease and effectiveness.Date :
- Date Completed 2001-04-12
- Date Revised 2018-11-13
Further Info :
Related Literature
Article Analysis
SNS
PICO Info
in preparation
Languages
English
Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.